Growth Metrics

Tectonic Therapeutic (TECX) Free Cash Flow (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Free Cash Flow data on record, last reported at -$18.4 million in Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 40.59% to -$18.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$65.6 million, a 4.03% decrease, with the full-year FY2025 number at -$60.3 million, down 1.77% from a year prior.
  • Free Cash Flow reached -$18.4 million in Q1 2026 per TECX's latest filing, down from -$14.5 million in the prior quarter.
  • Over the last five years, Free Cash Flow for TECX hit a ceiling of -$473000.0 in Q2 2023 and a floor of -$29.2 million in Q2 2022.
  • A 5-year average of -$16.3 million and a median of -$16.2 million in 2022 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: skyrocketed 98.38% in 2023, then plummeted 2728.33% in 2024.
  • Tracing TECX's Free Cash Flow over 5 years: stood at -$23.9 million in 2022, then skyrocketed by 51.1% to -$11.7 million in 2023, then tumbled by 43.71% to -$16.8 million in 2024, then rose by 14.05% to -$14.5 million in 2025, then decreased by 27.46% to -$18.4 million in 2026.
  • Business Quant data shows Free Cash Flow for TECX at -$18.4 million in Q1 2026, -$14.5 million in Q4 2025, and -$18.0 million in Q3 2025.